Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment - PubMed (original) (raw)
Clinical Trial
Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment
E C Tramont et al. J Clin Invest. 1981 Oct.
Abstract
A gonococcal pilus vaccine or placebo was injected subcutaneously or intramuscularly into 71 human volunteers. The vaccine was found to be safe. The principal adverse reaction was a complaint of a sore arm, which was caused, at least in part, to the volume of material injected. 6 of 64 (9%) volunteers receiving the larger doses also complained of malaise. The vaccine was found to be antigenic. All of the volunteers developed an immunoglobulin class-specific antibody response as measured by a solid phase radioimmunoassay. The antibody was capable of blocking the attachment of gonococci to epithelial cells. A slight antibody response was also demonstrated to gonococcal lipopolysaccharide but the antibody responsible for blocking attachment of gonococci was directed entirely at the pilus protein. The stimulated antibodies were shown to crossreact with isolated pili of heterologous gonococcal strains and to block the attachment of heterologous gonococci. Absorption of immune sera by a heterologous pilus reduced the inhibition of attachment antibodies to pre-immune level, suggesting that the immune response was directed at a common pilus determinant.
Similar articles
- Genital antibody response to a parenteral gonococcal pilus vaccine.
McChesney D, Tramont EC, Boslego JW, Ciak J, Sadoff J, Brinton CC. McChesney D, et al. Infect Immun. 1982 Jun;36(3):1006-12. doi: 10.1128/iai.36.3.1006-1012.1982. Infect Immun. 1982. PMID: 6124502 Free PMC article. - Efficacy trial of a parenteral gonococcal pilus vaccine in men.
Boslego JW, Tramont EC, Chung RC, McChesney DG, Ciak J, Sadoff JC, Piziak MV, Brown JD, Brinton CC Jr, Wood SW, et al. Boslego JW, et al. Vaccine. 1991 Mar;9(3):154-62. doi: 10.1016/0264-410x(91)90147-x. Vaccine. 1991. PMID: 1675029 Clinical Trial. - Pili as a mediator of the attachment of gonococci to human erythrocytes.
Buchanan TM, Pearce WA. Buchanan TM, et al. Infect Immun. 1976 May;13(5):1483-9. doi: 10.1128/iai.13.5.1483-1489.1976. Infect Immun. 1976. PMID: 818026 Free PMC article. - Pilus vaccines.
Tramont EC, Boslego JW. Tramont EC, et al. Vaccine. 1985 Mar;3(1):3-10. doi: 10.1016/0264-410x(85)90003-9. Vaccine. 1985. PMID: 2408396 Review. - [Gonococcal surface antigens and their significance for serotyping and vaccines].
Kohl PK, Meyer TF, Petzoldt D. Kohl PK, et al. Hautarzt. 1985 Jun;36(6):320-5. Hautarzt. 1985. PMID: 2862130 Review. German.
Cited by
- Neisseria gonorrhoeae vaccines: a contemporary overview.
Williams E, Seib KL, Fairley CK, Pollock GL, Hocking JS, McCarthy JS, Williamson DA. Williams E, et al. Clin Microbiol Rev. 2024 Mar 14;37(1):e0009423. doi: 10.1128/cmr.00094-23. Epub 2024 Jan 16. Clin Microbiol Rev. 2024. PMID: 38226640 Review. - Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
Edwards JL, Jennings MP, Apicella MA, Seib KL. Edwards JL, et al. Crit Rev Microbiol. 2016 Nov;42(6):928-41. doi: 10.3109/1040841X.2015.1105782. Epub 2016 Jan 23. Crit Rev Microbiol. 2016. PMID: 26805040 Free PMC article. Review. - Neisseria meningitidis Type IV Pili Composed of Sequence Invariable Pilins Are Masked by Multisite Glycosylation.
Gault J, Ferber M, Machata S, Imhaus AF, Malosse C, Charles-Orszag A, Millien C, Bouvier G, Bardiaux B, Péhau-Arnaudet G, Klinge K, Podglajen I, Ploy MC, Seifert HS, Nilges M, Chamot-Rooke J, Duménil G. Gault J, et al. PLoS Pathog. 2015 Sep 14;11(9):e1005162. doi: 10.1371/journal.ppat.1005162. eCollection 2015 Sep. PLoS Pathog. 2015. PMID: 26367394 Free PMC article. - Sequence, distribution and chromosomal context of class I and class II pilin genes of Neisseria meningitidis identified in whole genome sequences.
Wörmann ME, Horien CL, Bennett JS, Jolley KA, Maiden MC, Tang CM, Aho EL, Exley RM. Wörmann ME, et al. BMC Genomics. 2014 Apr 1;15:253. doi: 10.1186/1471-2164-15-253. BMC Genomics. 2014. PMID: 24690385 Free PMC article. - Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain.
Li G, Xie R, Zhu X, Mao Y, Liu S, Jiao H, Yan H, Xiong K, Ji M. Li G, et al. PLoS One. 2014 Mar 4;9(3):e90525. doi: 10.1371/journal.pone.0090525. eCollection 2014. PLoS One. 2014. PMID: 24594737 Free PMC article.
References
- J Exp Med. 1971 Oct 1;134(4):886-906 - PubMed
- J Exp Med. 1973 Mar 1;137(3):571-89 - PubMed
- Infect Immun. 1973 Mar;7(3):373-9 - PubMed
- Infect Immun. 1973 Jul;8(1):98-104 - PubMed
- J Infect Dis. 1974 Mar;129(3):310-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical